Subcellular activation of β-adrenergic receptors using a spatially restricted antagonist
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2404243121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Federica Liccardo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Institute, Department of Biochemistry & Biophysics, University of California, San Francisco, CA 94143. Hauptthemen laut MEDLINE: Cell Membrane, Receptors, Adrenergic, beta-1. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | NCI | Center for Cancer Research (CCR), NIGMS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Gprotein-coupled receptors (GPCRs) regulate several physiological and pathological processes and represent the target of approximately 30% of Food and Drug Administration-approved drugs. GPCR-mediated signaling was thought to occur exclusively at the plasma membrane. However, recent studies have unveiled their presence and function at subcellular membrane compartments. There is a growing interest in studying compartmentalized signaling of GPCRs. This requires development of tools to separate GPCR signaling at the plasma membrane from the ones initiated at intracellular compartments. We leveraged the structural and pharmacological information available for β-adrenergic receptors (βARs) and focused on β1AR as exemplary GPCR that functions at subcellular compartments, and rationally designed spatially restricted antagonists. We generated a cell-impermeable βAR antagonist by conjugating a suitable pharmacophore to a sulfonate-containing fluorophore. This cell-impermeable antagonist only inhibited β1AR on the plasma membrane. In contrast, a cell-permeable βAR antagonist containing a nonsulfonated fluorophore efficiently inhibited both the plasma membrane and Golgi pools of β1ARs. Furthermore, the cell-impermeable antagonist selectively inhibited the phosphorylation of PKA downstream effectors near the plasma membrane, which regulate sarcoplasmic reticulum (SR) Ca 2+ release in adult cardiomyocytes, while the β1AR Golgi pool remained active. Our tools offer promising avenues for investigating compartmentalized βAR signaling in various contexts, potentially advancing our understanding of βAR-mediated cellular responses in health and disease. They also offer a general strategy to study compartmentalized signaling for other GPCRs in various biological systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Research Institute, Department of Biochemistry & Biophysics, University of California, San Francisco, CA 94143.
- Department of Biochemistry & Biophysics, University of California, San Francisco, CA 94143.
- Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94143.
- HHMI, University of California, San Francisco, CA 94143.
ORCID-Profile: Federica Liccardo, Di Lang, Roshanak Irannejad
Förderung
- HHS | NIH | NCI | Center for Cancer Research (CCR)
- NIGMS NIH HHS
- NCI NIH HHS
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
Zitieren
APA
Liccardo, F., Morstein, J., Lin, T. Y., Pampel, J., Lang, D., Shokat, K. M., & Irannejad, R. (2024). Subcellular activation of β-adrenergic receptors using a spatially restricted antagonist. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2404243121
Vancouver
Liccardo F, Morstein J, Lin TY, Pampel J, Lang D, Shokat KM, et al. Subcellular activation of β-adrenergic receptors using a spatially restricted antagonist. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2404243121
BibTeX
@article{Liccardo2024,
author = {Liccardo, Federica and Morstein, Johannes and Lin, Ting-Yu and Pampel, Julius and Lang, Di and Shokat, Kevan M and Irannejad, Roshanak},
title = {Subcellular activation of β-adrenergic receptors using a spatially restricted antagonist},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2404243121}
}
EUVIMED